查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529810

經皮皮膚貼片市場規模、佔有率和趨勢分析報告：按類型、按應用、按分銷管道、按地區和細分市場預測，2024-2030

Transdermal Skin Patches Market Size, Share & Trends Analysis Report By Type (Multi-layer Drug-in-Adhesive), By Application (Pain Relief), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 170 Pages | 商品交期: 2-10個工作天內

價格

經皮貼片市場趨勢

2023年，全球經皮皮膚貼片市場預計將達到78.2億美元，預計2024年至2030年複合年成長率為5.0%。心血管疾病、糖尿病和慢性疼痛等慢性疾病的盛行率不斷上升，消費者對微創治療的偏好不斷提高，全球人口老化以及經皮給藥系統的技術進步正在顯著推動市場發展。

經皮皮膚貼片是傳統口服和注射藥物的非侵入性且方便的替代品。提高患者的依從性並盡量減少口服藥物常見的胃腸道副作用。這種易用性和長時間穩定的藥物釋放使得經皮皮膚貼片對於慢性疾病的治療特別有吸引力。

該市場正在經歷顯著成長，主要是由於全球慢性病的盛行率不斷上升。根據美國疾病管制與預防中心 (CDC) 2024 年 2 月發布的報告，估計美國有 1.29 億人患有至少一種主要慢性疾病，包括癌症、心臟病、肥胖、糖尿病和高血壓。治療慢性疼痛通常需要定期服用止痛藥，但由於副作用和頻繁給藥，口服和注射藥物可能很麻煩。

經皮皮膚貼片提供了一種解決方案，可以在較長時間內控制藥物釋放，提高患者的依從性並改善治療結果。例如，用於治療嚴重慢性疼痛的Fentanyl經皮皮膚貼片可提供連續 72 小時的藥物劑量，減少了頻繁給藥的需要並維持穩定的疼痛緩解。

微針、離子電滲療法和滲透促進劑等藥物傳遞系統的創新大大擴展了經皮給藥的範圍，包括大分子和生技藥品。微針貼片在皮膚上形成微小的凹槽，使得難以經皮給藥的聚合物藥物成為可能。一個顯著的例子是用來注射胰島素給糖尿病患者的微針貼片。這是日常注射的無痛治療方法，可以改善血糖控制。另一項突破性技術是離子電滲透療法，它利用微小的電荷來增加藥物對皮膚的滲透。例如，IontoPatch 提供發炎劑來治療肌腱炎和黏液囊炎等疾病，從而增加藥物的吸收和有效性。這些進步提高了經皮系統的效率和可靠性，並引入了新的治療可能性，推動了市場成長並擴大了可透過非侵入性手段治療的疾病範圍。

消費者對微創治療的偏好不斷增加是市場的主要驅動力。與口服藥物或注射相比，患者和醫療保健提供者青睞這種貼片，因為它能緩解疼痛、降低感染風險，且副作用更少。例如，Biochemie Novartis 的 Estraderm Mx Patch 是一種荷爾蒙補充療法貼劑，可穩定釋放激素，從而最大限度地減少與口服 HRT 水平波動相關的副作用。此外，用於戒菸、疼痛管理和神經系統疾病的貼片描述了謹慎且方便的藥物輸送方法。這種非侵入性方法提高了患者的舒適度和依從性，隨著人們對這些好處的認知的傳播，推動了市場的成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章經皮經皮貼片市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 助劑市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業分析-波特五力分析
    • PESTEL分析

第4章經皮經皮貼片市場：類型、估計和趨勢分析

  • 細分儀表板
  • 經皮皮膚貼片市場：類型變化分析，2023 年和 2030 年

第5章經皮貼片市場：應用、估計與趨勢分析

  • 細分儀表板
  • 經皮皮膚貼片市場：2023 年和 2030 年應用變化分析

第6章經皮經皮貼片市場：通路、估計與趨勢分析

  • 細分儀表板
  • 經皮貼片市場：2023 年與 2030 年通路變化分析

第7章經皮貼片市場：區域、估計與趨勢分析

  • 2023 年及 2030 年按地區分類的市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 2023年主要企業市場佔有率分析
    • Teva Pharmaceutical Industries Ltd
    • Novartis AG
    • Teikoku Pharma USA Inc.
    • Viatris Inc.
    • Johnson &Johnson
    • Luye Pharma Group
    • Purdue Pharma Manufacturing LP
    • Henan Lingrui Pharmaceutical Ltd
    • Samyang Biopharmaceuticals Corp.
    • Hisamitsu Pharmaceutical Co, Inc.
Product Code: GVR-4-68040-361-1

Transdermal Skin Patches Market Trends

The global transdermal skin patches market was estimated at USD 7.82 billion in 2023 and is projected to grow at a CAGR of 5.0% from 2024 to 2030. The rising prevalence of chronic diseases such as cardiovascular disorders, diabetes, chronic pain, etc., increased consumer preference for minimally invasive treatment, the aging global population, and technological advancements in transdermal drug delivery systems have significantly boosted the market.

Transdermal patches provide a noninvasive, convenient alternative to traditional oral and injectable medications. They enhance patient compliance and minimize the gastrointestinal side effects that often accompany oral drugs. This ease of use and consistent drug release over extended periods make transdermal patches particularly attractive for managing chronic conditions.

The market is experiencing significant growth, primarily driven by the increasing prevalence of chronic diseases worldwide. According to the CDC report published in February 2024, an estimated 129 million people in the U.S. have at least 1 major chronic disease, such as cancer, heart disease, obesity, diabetes, and hypertension. Managing chronic pain typically involves regular administration of pain relief medication, which can be cumbersome with oral or injectable forms due to their side effects and the need for frequent dosing.

Transdermal patches offer a solution by providing a controlled release of medication over extended periods, which enhances patient compliance and improves therapeutic outcomes. For instance, the fentanyl transdermal patch, used for managing severe chronic pain, delivers the drug continuously for 72 hours, reducing the need for frequent dosing and maintaining steady pain relief.

Innovations in drug delivery systems, including microneedles, iontophoresis, and permeation enhancers, have significantly broadened the scope of transdermal medication delivery, accommodating large molecules and biologics. Microneedle patches create microscopic channels in the skin, enabling the administration of large molecule drugs that are otherwise difficult to deliver transdermal. A notable example is the microneedle patch for insulin delivery in diabetic patients, which offers a painless alternative to daily injections, potentially improving glycemic control. Iontophoresis, another breakthrough technology, employs a small electric charge to enhance drug penetration through the skin. For instance, IontoPatch delivers anti-inflammatory drugs to treat conditions like tendinitis and bursitis, increasing the drug's absorption and effectiveness. These advancements boost the efficiency and reliability of transdermal delivery systems and introduce new therapeutic possibilities, driving market growth and expanding the range of treatable conditions through non-invasive means.

The rising consumer preference for minimally invasive treatments significantly drives the market. Patients and healthcare providers favor these patches for reduced pain, lower infection risk, and fewer side effects than oral medications or injections. For instance, hormone replacement therapy patches Estraderm Mx Patch by Biochemie Novartis offer a steady hormone release, minimizing side effects linked to fluctuating levels seen with oral HRT. In addition, patches for smoking cessation, pain management, and neurological disorders provide a discreet and convenient drug delivery method. This non-invasive approach enhances patient comfort and compliance, boosting the market growth as awareness of these benefits spreads.

Global Transdermal Skin Patches Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest trends in each of the sub-segments from 2018 to 2030. For this report, Grand View Research has segmented the global transdermal skin patches market based on type, application, distribution channel, and region:

  • Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Single-layer Drug-in-Adhesive
  • Multi-layer Drug-in-Adhesive
  • Matrix
  • Other Types
  • Application Outlook (Revenue, USD Billion, 2018 - 2030)
  • Pain Relief
  • Smoking Reduction and Cessation Aid
  • Cardiovascular Disorders
  • Neurological Disorders
  • Hormonal Therapy
  • Other Applications
  • Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Outlook (Revenue, USD Billion, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

Japan

China

India

South Korea

Australia

Thailand

  • Latin America

Brazil

Argentina

  • Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Application
    • 1.2.3. Distribution Channel
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application Outlook
    • 2.2.3. Distribution Channel Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Transdermal Skin Patches Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Industry Analysis - Porter's
      • 3.2.3.1. Bargaining power of the suppliers
      • 3.2.3.2. Bargaining power of the buyers
      • 3.2.3.3. Threats of substitution
      • 3.2.3.4. Threats from new entrants
      • 3.2.3.5. Competitive rivalry
    • 3.2.4. PESTEL Analysis
      • 3.2.4.1. Political landscape
      • 3.2.4.2. Economic and Social landscape
      • 3.2.4.3. Technological landscape

Chapter 4. Transdermal Skin Patches Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Transdermal Skin Patches Market: Type Movement Analysis, 2023 & 2030 (USD Billion)
    • 4.2.1. Single-layer Drug-in-Adhesive
      • 4.2.1.1. Single-layer Drug-in-Adhesive Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 4.2.2. Multi-layer Drug-in-Adhesive
      • 4.2.2.1. Multi-layer Drug-in-Adhesive Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 4.2.3. Matrix
      • 4.2.3.1. Matrix Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 4.2.4. Other Types
      • 4.2.4.1. Other Types Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Transdermal Skin Patches Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Transdermal Skin Patches Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
    • 5.2.1. Pain Relief
      • 5.2.1.1. Pain Relief Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 5.2.2. Smoking Reduction
      • 5.2.2.1. Smoking Reduction Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 5.2.3. Cardiovascular Disorders
      • 5.2.3.1. Cardiovascular Disorders Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 5.2.4. Neurological Disorders
      • 5.2.4.1. Neurological Disorders Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 5.2.5. Hormonal Therapy
      • 5.2.5.1. Hormonal Therapy Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 5.2.6. Other Applications
      • 5.2.6.1. Other Applications Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Transdermal Skin Patches Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Transdermal Skin Patches Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Billion)
    • 6.2.1. Hospital Pharmacies
      • 6.2.1.1. Hospital Pharmacies Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.2. Retail Pharmacies
      • 6.2.2.1. Retail Pharmacies Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.3. Online Pharmacies
      • 6.2.3.1. Online Pharmacies Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Transdermal Skin Patches Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Billion)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Billion)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key company market share analysis, 2023
    • 8.3.2. Teva Pharmaceutical Industries Ltd
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Type benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Novartis AG
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Type benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Teikoku Pharma USA Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Type benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Viatris Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Type benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Johnson & Johnson
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Type benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Luye Pharma Group
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Type benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Purdue Pharma Manufacturing LP
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Type benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Henan Lingrui Pharmaceutical Ltd
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Type benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Samyang Biopharmaceuticals Corp.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Type benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Hisamitsu Pharmaceutical Co, Inc.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Type benchmarking
      • 8.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 Global Transdermal Skin Patches Market, By Region, 2018 - 2030 (USD Billion)
  • Table 5 Global Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 6 Global Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 7 Global Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 8 North America Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
  • Table 9 North America Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 10 North America Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 11 North America Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 12 U.S. Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 13 U.S. Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 14 U.S. Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 15 Canada Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 16 Canada Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 17 Canada Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 18 Mexico Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 19 Mexico Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 20 Mexico Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 21 Europe Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
  • Table 22 Europe Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 23 Europe Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 24 Europe Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 25 UK Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 26 UK Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 27 UK Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 28 Germany Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 29 Germany Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 30 Germany Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 31 France Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 32 France Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 33 France Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 34 Italy Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 35 Italy Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 36 Italy Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 37 Spain Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 38 Spain Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 39 Spain Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 40 Denmark Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 41 Denmark Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 42 Denmark Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 43 Sweden Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 44 Sweden Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 45 Sweden Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 46 Norway Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 47 Norway Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 48 Norway Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 49 Asia Pacific Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
  • Table 50 Asia Pacific Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 51 Asia Pacific Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 52 Asia Pacific Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 53 Japan Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 54 Japan Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 55 Japan Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 56 China Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 57 China Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 58 China Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 59 India Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 60 India Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 61 India Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 62 South Korea Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 63 South Korea Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 64 South Korea Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 65 Australia Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 66 Australia Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 67 Australia Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 68 Thailand Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 69 Thailand Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 70 Thailand Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 71 Latin America Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
  • Table 72 Latin America Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 73 Latin America Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 74 Latin America Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 75 Brazil Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 76 Brazil Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 77 Brazil Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 78 Argentina Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 79 Argentina Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 80 Argentina Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 81 Middle East and Africa Transdermal Skin Patches Market, By Country, 2018 - 2030 (USD Billion)
  • Table 82 Middle East and Africa Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 83 Middle East and Africa Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 84 Middle East & Africa Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 85 South Africa Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 86 South Africa Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 87 South Africa Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 88 Saudi Arabia Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 89 Saudi Arabia Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 90 Saudi Arabia Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 91 UAE Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 92 UAE Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 93 UAE Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)
  • Table 94 Kuwait Transdermal Skin Patches Market, By Type, 2018 - 2030 (USD Billion)
  • Table 95 Kuwait Transdermal Skin Patches Market, By Application, 2018 - 2030 (USD Billion)
  • Table 96 Kuwait Transdermal Skin Patches Market, By Distribution Channel, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Transdermal Skin Patches market segment scope and defination
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Transdermal Skin Patches market: Type movement analysis
  • Fig. 17 Transdermal Skin Patches market: Type segment dashboard
  • Fig. 18 Transdermal Skin Patches market Type outlook: Key takeaways
  • Fig. 19 Single-layer Drug-in-Adhesive Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 20 Multi-layer Drug-in-AdhesiveTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 21 MatrixTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Other TypesTransdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Transdermal Skin Patches market: Application movement analysis
  • Fig. 24 Transdermal Skin Patches market Application outlook: Key takeaways
  • Fig. 25 Pain Relief Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 26 Smoking Reduction and Cessation Aid Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 27 Cardiovascular Disorders Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Neurological Disorders Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Hormonal Therapy Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 30 Other Applications Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 31 Transdermal Skin Patches market: Distribution Channel movement analysis
  • Fig. 32 Transdermal Skin Patches market Distribution Channel outlook: Key takeaways
  • Fig. 33 Hospital Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Retail Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Online Pharmacies Transdermal Skin Patches market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 36 Regional outlook, 2023 & 2030
  • Fig. 37 Regional market dashboard
  • Fig. 38 Regional market place: Key takeaways
  • Fig. 39 North America Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 40 U.S. Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 41 Canada Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 42 Europe Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 43 UK Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 44 Germany Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 45 Spain Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 46 France Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 47 Italy implantable Market, 2018 - 2030 (USD Billion)
  • Fig. 48 Denmark Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 49 Sweden Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 50 Norway Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 51 Asia Pacific Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 52 Japan Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 53 China Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 54 India Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 55 South Korea Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 56 Australia Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 57 Thailand Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 58 Latin America Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 59 Brazil Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 60 Mexico Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 61 Argentina Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 62 MEA Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 63 South Africa Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 64 Saudi Arabia Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 65 UAE Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 66 Kuwait Transdermal Skin Patches Market, 2018 - 2030 (USD Billion)
  • Fig. 67 Heat map analysis
  • Fig. 68 Market differentiators